On November 3, 2025, Vor Biopharma announced the appointment of Dr Jeremy Sokolove as Chief Medical Officer. Dr Sokolove brings extensive experience in rheumatology and autoimmune disease research to advance the company's clinical strategy.
Who to call at Vor Bio, and when
A new leader at Vor Bio brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Vor Bio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Vor Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vor Bio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Vor Bio
Location
Cambridge, Massachusetts, United States
About
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vor Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeOtherBiotechnologyHealth CareTherapeutics